The DOI matches its Crossref record; 232 of the 233 references it cites were found in a registry or an index.
Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms
Open accessAbstract
Exercise training improves nonalcoholic fatty liver disease (NAFLD) as well as obesity and metabolic diseases. Although it is difficult to eliminate the effects of body weight reduction and increased energy expenditure, which are among the pleiotropic effects of exercise training, a number of clinical and experimental studies involving either aerobic exercise training or resistance training programs show improvements in NAFLD that are independent of the improvements in obesity and insulin resistance. In vivo studies have identified effects of exercise training on the liver, which may help to explain the “direct” or “independent” effect of exercise training on NAFLD. Exercise training increases peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) expression, improves mitochondrial function and leads to reduced hepatic steatosis, inflammation, fibrosis, and tumor genesis. Crosstalk of liver to adipose tissue, skeletal muscle and the microbiome is also a possible mechanism for the effect of exercise training on NAFLD. Although numerous clinical and experimental studies have reported benefits of exercise training on NAFLD, the optimal duration and intensity of exercise for the prevention or treatment of NAFLD have not been established. Maintaining adherence of NAFLD patients to exercise training is another issue to be resolved. The use of comprehensive analytical approaches to identify biomarkers such as hepatokines that specifically reflect the effect of exercise training on liver may help to monitor the exercise effect on NAFLD, and thereby improve adherence of NAFLD patients to exercise training. Exercise training is a robust approach for improving NAFLD pathogenesis, though further clinical and experimental study is required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exercise reduces hepatic steatosis independently of weight loss105.”
From Exerkines in health, resilience and disease (2022) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.004 · Cited by 4,836
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Physical activity/exercise and diabetes: A position statement of the American Diabetes Association
Colberg, S. R., Sigal, R. J., Yardley, J. E., Riddell, M. C., Dunstan, D. W., Dempsey, P. C., Horton, E. S., Castorino, K., & Tate, D. F. (2016) · Diabetes Care · doi:10.2337/dc16-1728 · Cited by 2,991
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Ekelund, U., Steene-Johannessen, J., Brown, W. J., Fagerland, M. W., Owen, N., Powell, K. E., Bauman, A., & Lee, I.-M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30370-1 · Cited by 2,648
Cited by
Sorted by citations
Exerkines in health, resilience and disease
Chow, L. S., Gerszten, R. E., Taylor, J. M., Pedersen, B. K., van Praag, H., Trappe, S., Febbraio, M. A., Galis, Z. S., Gao, Y., Haus, J. M., et al. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00641-2 · Cited by 927
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Schwabe, R. F., Tabas, I., & Pajvani, U. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.311 · Cited by 671
Amount and Intensity of Leisure-Time Physical Activity and Lower Cancer Risk
Matthews, C. E., Moore, S. C., Arem, H., Cook, M. B., Trabert, B., Håkansson, N., Larsson, S. C., Wolk, A., Gapstur, S. M., Lynch, B. M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02407 · Cited by 294
Battista, F., Ermolao, A., van Baak, M. A., Beaulieu, K., Blundell, J. E., Busetto, L., Carraça, E. V., Encantado, J., Dicker, D., Farpour‐Lambert, N. J., et al. (2021) · Obesity Reviews · doi:10.1111/obr.13269 · Cited by 167
Kwon, J., Lee, C., Heo, S., Kim, B., & Hyun, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-84761-1 · Cited by 127
Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover
Simón, J., Ouro, A., Ala-Ibanibo, L., Presa, N., Delgado, T. C., & Martínez‐Chantar, M. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010040 · Cited by 127
Myokines in metabolic homeostasis and diabetes
Eckel, J. (2019) · Diabetologia · doi:10.1007/s00125-019-4927-9 · Cited by 113
Mediterranean diet and NAFLD: what we know and questions that still need to be answered
Plaz Torres, M. C., Aghemo, A., Lleo, A., Bodini, G., Furnari, M., Marabotto, E., Miele, L., & Giannini, E. G. (2019) · Nutrients · doi:10.3390/nu11122971 · Cited by 97
Importance of fatigue and its measurement in chronic liver disease
Gerber, L. H., Weinstein, A. A., Mehta, R., & Younossi, Z. M. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i28.3669 · Cited by 94
Role of exercise-induced hepatokines in metabolic disorders
Ennequin, G., Sirvent, P., & Whitham, M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00433.2018 · Cited by 54
Xiong, Y., Peng, Q., Cao, C., Xu, Z., & Zhang, B. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18063242 · Cited by 53
Roberts, F. L., & Markby, G. R. (2021) · Cells · doi:10.3390/cells10102639 · Cited by 54
Kamada, Y., Takahashi, H., Shimizu, M., Kawaguchi, T., Sumida, Y., Fujii, H., Seko, Y., Fukunishi, S., Tokushige, K., Nakajima, A., et al. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01833-9 · Cited by 43
Self-citationAerobic Exercise in the Management of Metabolic Dysfunction Associated Fatty Liver Disease
Machado, M. V. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s304357 · Cited by 43
Juszczak, F., Vlassembrouck, M., Botton, O., Zwakhals, T., Decarnoncle, M., Tassin, A., Caron, N., & Declèves, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010350 · Cited by 35
Hepatokines as a Molecular Transducer of Exercise
Seo, D. Y., Park, S.-H., Marquez, J. C., Kwak, H., Kim, T. N., Bae, J. H., Koh, J., & Han, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030385 · Cited by 37
Pan, X.-T., Xie, X.-X., Peng, H.-W., Cai, X.-L., Li, H.-Q., Hong, Q.-Z., Wu, Y.-L., Lin, X., Xu, S., & Peng, X.-E. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00220 · Cited by 23
Hoene, M., Kappler, L., Kollipara, L., Hu, C., Irmler, M., Bleher, D., Hoffmann, C., Beckers, J., de Angelis, M. H., Häring, H., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101359 · Cited by 32
Rajewski, P., Cieściński, J., Rajewski, P., Suwała, S., Rajewska, A., & Potasz, M. (2025) · Biomedicines · doi:10.3390/biomedicines13010217 · Cited by 29
Kobayashi, T., Kessoku, T., Ozaki, A., Iwaki, M., Honda, Y., Ogawa, Y., Imajo, K., Yoneda, M., Saito, S., & Nakajima, A. (2021) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.20-142 · Cited by 24
Karunanayake, A. L., Senaratne, C. D., & Stathi, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232956 · Cited by 24
Effects of nonalcoholic fatty liver disease on sarcopenia: evidence from genetic methods
Yuan, J., Zhang, J., Luo, Q., & Peng, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-53112-1 · Cited by 20
Perspectives on Interval Exercise Interventions for Non-Alcoholic Fatty Liver Disease
Hamasaki, H. (2019) · Medicines · doi:10.3390/medicines6030083 · Cited by 19
Iwanaga, S., Hashida, R., Takano, Y., Bekki, M., Nakano, D., Omoto, M., Nago, T., Kawaguchi, T., Matsuse, H., Torimura, T., et al. (2020) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.252.23 · Cited by 16
Choi, E.-Y., Choi, J. O., Park, C. Y., Kim, S., & Kim, D.-H. (2020) · Journal of Medicinal Food · doi:10.1089/jmf.2020.4696 · Cited by 17
Boeckmans, J., Gatzios, A., Heymans, A., Rombaut, M., Rogiers, V., Kock, J. D., Vanhaecke, T., & Rodrigues, R. M. (2022) · Cells · doi:10.3390/cells11050893 · Cited by 13
Price, P. H., Kaizer, A. M., Inge, T. H., & Eckel, R. H. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0585-8 · Cited by 12
Curci, R., Bianco, A., Franco, I., Campanella, A., Mirizzi, A., Bonfiglio, C., Sorino, P., Fucilli, F., Giovanni, G. D., Giampaolo, N., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154339 · Cited by 12
Jun-han, L., Huang, L., Xiong, W., Gu, C., Zhang, S., & Xue, X. (2022) · Sports Medicine and Health Science · doi:10.1016/j.smhs.2022.11.002 · Cited by 10
Control of inflammatory lung injury and repair by metabolic signaling in endothelial cells
Gould, S., Herron, A., Davis, J., Phillips, M., Chakrabarti, M., & Evans, C. E. (2024) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000848 · Cited by 9
Exerkines: Potential regulators of ferroptosis
Jia, M., Li, F., Wu, T., & Chen, N. (2025) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2025.101032 · Cited by 10
Bianco, A., Franco, I., Curci, R., Bonfiglio, C., Campanella, A., Mirizzi, A., Fucilli, F., Giovanni, G. D., Giampaolo, N., Pesole, P. L., et al. (2023) · Nutrients · doi:10.3390/nu15102252 · Cited by 8
The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC)
Venniyoor, A., Farsi, A. M. A., & Bahrani, B. J. A. (2021) · Cureus · doi:10.7759/cureus.17320 · Cited by 8
Sadeghiyan, S., Ghafari, M., Faramarzi, M., Moghaddam, M., & Baghurst, T. M. (2022) · The Journal of Sports Medicine and Physical Fitness · doi:10.23736/s0022-4707.22.13801-6 · Cited by 9
Iwanaga, S., Matsuse, H., Hashida, R., Bekki, M., Kawaguchi, T., & Shiba, N. N. (2020) · The Kurume Medical Journal · doi:10.2739/kurumemedj.ms674001 · Cited by 7
Gene therapy targeting miR‑212‑3p exerts therapeutic effects on MAFLD similar to those of exercise
Sun, B., Zhang, Y., Zhang, M., Liu, R., & Yang, W. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5219 · Cited by 7
Exercise training ameliorates carbon tetrachloride-induced liver fibrosis and anxiety-like behaviors
Tomiga, Y., Tanaka, K., Kusuyama, J., Takano, A., Higaki, Y., Anzai, K., & Takahashi, K. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00161.2024 · Cited by 8
Self-citationShort-Term Inspiratory Muscle Training Enhances Functional and Metabolic Health in Older Adults
Konca, E., Yılmaz, C., Bayrakdaroğlu, S., Ceylan, H. İ., Arslan, A., Ocak, H., Karakulak, İ., Sarı, R., Uzun, R. N., Soylu, H. H., et al. (2026) · Healthcare · doi:10.3390/healthcare14020249 · Cited by 4
Qu, Y., Yh, S., Sun, R., Ma, Y., & Zhang, Y. (2024) · Physiological Research · doi:10.33549/physiolres.935164 · Cited by 4
Du, X., Hu, J., Xue, J., Zhuang, Y., Tang, X., & Xu, Z. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s466980 · Cited by 4
Fuentes-Barría, H., Aguilera-Eguía, R. A., Flores-Fernández, C., Angarita, L., & Alarcón-Rivera, M. (2026) · Biomedicines · doi:10.3390/biomedicines14030577 · Cited by 3
Yuan, X.-M., Xiang, M.-Q., Ping, Y., Zhang, P.-W., Yt, L., Liu, X.-W., Wei, J., Tang, Q., & Zhang, Y. (2024) · PubMed Central · doi:10.33549/physiolres.935195 · Cited by 3
Eslami, Z., Ghafi, A. G., Wong, A., Asghari, S. H., Asadi, N., & Mirghani, S. J. (2026) · Scientific Reports · doi:10.1038/s41598-026-35546-x · Cited by 2
Sheptulina, A. F., Golubeva, J. A., Kiselev, A. R., & Drapkina, O. M. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i10.110848 · Cited by 2
Fathy, M., Zamzam, M., Gerges, N., Hendy, N. I., Abdelfattah, M. T., & Alsemeh, A. E. (2023) · Zagazig University Medical Journal · doi:10.21608/zumj.2023.197729.2760 · Cited by 1
Growing muscle against cirrhosis: In the quest for models to revealing mechanisms
Asensio, I., & Vaquero, J. (2019) · Liver International · doi:10.1111/liv.14032
Sadeghiyan, S., Ghafari, M., Faramarzi, M., Moghaddam, M., & Baghurst, T. M. (2021) · Research Square · doi:10.21203/rs.3.rs-573993/v1
Potential targets for prevention and treatment of non-alcoholic fatty liver disease in adults
Braich, J. S. (2020) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20205134
Porras, D. (2021) · Buleria (Universidad de León) · doi:10.18002/10612/13641
Impact of physical exercise on metabolic dysfunction-associated fatty liver disease (MAFLD)
Sales, S. T., Gasparini, P. V. F., Madureira, A. R., Cordeiro, J. P., Leopoldo, A. S., & Lima‐Leopoldo, A. P. (2023) · Brazilian Journal of Development · doi:10.34117/bjdv9n1-053 · Cited by 1
武, 云. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1371538
Practical Clinical Cases in Nonalcoholic Fatty Liver Disease
Stratina, E., Rotaru, A., Stafie, R., & Minea, H. O. (2023) · Springer eBooks · doi:10.1007/978-3-031-33548-8_22
Cross-talk between hepatokines as Liver indused-exercise factors and organokinesPreprint
Rad, R. S. (2023) · Research Square · doi:10.21203/rs.3.rs-3734627/v1
Shen, Y., Chen, M., Zhu, S., Lin, J., Liu, L., Zhu, C. K., Zhu, J., & Cm, X. (2026) · Journal of International Medical Research · doi:10.1177/03000605261467633
Asif, M. A., Masood, S., Akbar, S. M. A., Khalid, M. H., Rehman, A., Imran, M., Suhaib, A., Asif, M. A., Khalid, A., Sohaib, M., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145737
Metadata
- Authors
- Takahashi, H., Kotani, K., Tanaka, K., Egucih, Y., & Anzai, K.
- Affiliations
- Saga University (JP)
- Jichi Medical University (JP)
- Corresponding author
- Anzai, Keizo
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2018-10-15
- Volume
- 9
- Pages
- 588-588
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC6196235
- OpenAlex
- W2897133585
- Cited by
- 55
- References
- 233
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 6 · 2023: 7 · 2022: 5 · 2021: 12 · 2020: 9 · 2019: 8
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Society for the Promotion of Science (16H07070, 18K15754)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Physiology (medical) › Exercise and Physiological Responses
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Physical Activity and Health
- Keywords
- non-alcoholic fatty liver disease, exercise training, aerobic exercise, resistance training, PGC-1α, mitochondrial function, hepatic steatosis, liver fibrosis, liver inflammation, gut-liver axis, microbiome, hepatokines, exercise adherence, biomarkers, obesity, insulin resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
